THEODORE SOLOMON: Open Payments
NPI 1073105078 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$125,782 in 220 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $5,200 · 2025 $125,782
Speaker / faculty: $91,930Travel & lodging: $25,471Consulting: $4,820Food & beverage: $3,560
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 89 | $62,050 |
| Lilly USA, LLC | 107 | $52,505 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $8,321 |
| Celltrion USA Inc. | 4 | $1,870 |
| ABBVIE INC. | 4 | $846 |
| PFIZER INC. | 1 | $189 |
Products named: TREMFYA, OMVOH, ENTYVIO, ZYMFENTRA, RINVOQ, STELARA, VELSIPITY, SKYRIZI.
Industry payments across CA — which companies pay providers there.
